Table 1.
Variable | N | (%) |
---|---|---|
Facility-level characteristics | ||
Women served by facility-level | ||
Hospital | 23,261 | (80.1) |
Health center | 4,141 | (14.3) |
Maternity home | 1,654 | (5.7) |
Women seen by type of provider | ||
House Officer | 2,799 | (9.6) |
Physician | 13,753 | (47.3) |
Midwife | 12,504 | (43.0) |
Women served by facility region | ||
Ashanti | 6,476 | (22.3) |
Eastern | 8,777 | (30.2) |
Greater Accra | 13,803 | (47.5) |
Client-level characteristics | ||
Client age (years) | ||
10-19 | 4,400 | (15.4) |
20-29 | 15,321 | (52.7) |
30-39 | 7,451 | (25.6) |
40-49 | 1,117 | (3.8) |
Missing | 767 | (2.6) |
Mean client age (SD), years | 26 | (6.7) |
Trimester | ||
1st Trimester | 24,077 | (82.9) |
2nd Trimester | 2,509 | (8.6) |
Missing | 2,470 | (8.5) |
Mean gestational age (SD), weeks | 8.6 | 4.2 |
Uterine evacuation procedure type | ||
MVA or EVA | 27,870 | (95.9) |
Medical abortiona | 1,083 | (3.7) |
D&C or D&E | 103 | (0.4) |
Indication for abortion | ||
Postabortion care | 17,019 | (58.6) |
Induced abortion | 12,037 | (41.4) |
Postabortion contraception received | ||
Short-acting methodb | 14,521 | (50.0) |
Long-acting and permanent methodc | 4,240 | (14.6) |
No method | 10,295 | (35.4) |
Type of postabortion contraception | ||
Male condom | 2,680 | (9.2) |
Female condom | 668 | (2.3) |
Oral contraceptives | 4,550 | (15.7) |
Injection | 6,553 | (22.6) |
Spermicide/Emergency contraception | 70 | (0.2) |
IUD | 1,347 | (4.6) |
Contraceptive implant | 2,799 | (9.6) |
Bilateral tubal ligation | 94 | (0.3) |
No method | 10,295 | (35.4) |
MVA, manual vacuum aspiration; EVA, electric vacuum aspiration; D&C, dilation & curettage; D&E, dilation & extraction; IUD, intra-uterine device
aMedical abortion refers to treatment with either misoprostol or a combination misoprostol and mifepristone
bShort-acting contraceptive method refers to: barrier methods, oral contraception, injectables, spermicide, emergency contraception
cLong-acting and permanent contraceptive method refers to: IUD, contraceptive implant, bilateral tubal ligation